- Home
- PHAT vs AMSF Comparison
PHAT vs AMSF Comparison
Compare PHAT & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- AMSF
- Stock Information
- Founded
- PHAT 2018
- AMSF 1985
- Country
- PHAT United States
- AMSF United States
- Employees
- PHAT N/A
- AMSF N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- AMSF Accident &Health Insurance
- Sector
- PHAT Health Care
- AMSF Finance
- Exchange
- PHAT Nasdaq
- AMSF Nasdaq
- Market Cap
- PHAT 1.2B
- AMSF 968.5M
- IPO Year
- PHAT 2019
- AMSF 2005
- Fundamental
- Price
- PHAT $8.78
- AMSF $58.14
- Analyst Decision
- PHAT Strong Buy
- AMSF Buy
- Analyst Count
- PHAT 4
- AMSF 2
- Target Price
- PHAT $22.50
- AMSF $59.50
- AVG Volume (30 Days)
- PHAT 1.9M
- AMSF 116.0K
- Earning Date
- PHAT 11-07-2024
- AMSF 10-23-2024
- Dividend Yield
- PHAT N/A
- AMSF 7.69%
- EPS Growth
- PHAT N/A
- AMSF N/A
- EPS
- PHAT N/A
- AMSF 3.21
- Revenue
- PHAT $26,270,000.00
- AMSF $315,182,000.00
- Revenue This Year
- PHAT $6,714.96
- AMSF N/A
- Revenue Next Year
- PHAT $293.69
- AMSF $1.81
- P/E Ratio
- PHAT N/A
- AMSF $18.15
- Revenue Growth
- PHAT N/A
- AMSF 2.81
- 52 Week Low
- PHAT $6.07
- AMSF $41.97
- 52 Week High
- PHAT $19.71
- AMSF $60.24
- Technical
- Relative Strength Index (RSI)
- PHAT 23.73
- AMSF 66.79
- Support Level
- PHAT $8.91
- AMSF $57.86
- Resistance Level
- PHAT $19.05
- AMSF $60.24
- Average True Range (ATR)
- PHAT 1.74
- AMSF 1.12
- MACD
- PHAT -1.05
- AMSF 0.15
- Stochastic Oscillator
- PHAT 2.19
- AMSF 74.96
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance to employers engaged in hazardous industries, mainly construction, trucking, manufacturing, oil and gas, and agriculture. The company generates a majority of its revenue in the form of premiums.